A dopamine transporter mutation associated with bipolar affective disorder causes inhibition of transporter cell surface expression.
about
Bipolar disorder and mechanisms of action of mood stabilizersInvestigating the mechanism(s) underlying switching between states in bipolar disorderInvestigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.Animal models of bipolar mania: The past, present and future.The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants.Predictive animal models of mania: hits, misses and future directions.A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to menHyperdopaminergia and NMDA receptor hypofunction disrupt neural phase signalingNoradrenergic control of cortico-striato-thalamic and mesolimbic cross-structural synchronyPersistent hyperdopaminergia decreases the peak frequency of hippocampal theta oscillations during quiet waking and REM sleepGBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior.The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administrationReduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorderThe catecholaminergic-cholinergic balance hypothesis of bipolar disorder revisited.Rodent versions of the iowa gambling task: opportunities and challenges for the understanding of decision-making.Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats.RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients.Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessationDifferential effects of dopamine transporter inhibitors in the rodent Iowa gambling task: relevance to mania.Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania.Dopamine transporter mutant animals: a translational perspective.Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice.Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder.Sequence determinants of the Caenhorhabditis elegans dopamine transporter dictating in vivo axonal export and synaptic localization.Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania.Striatal dopamine transporter availability in unmedicated bipolar disorder.Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice.Animal models for bipolar disorder: from bedside to the cage.The effects of reduced dopamine transporter function and chronic lithium on motivation, probabilistic learning, and neurochemistry in mice: Modeling bipolar mania.Mice with reduced DAT levels recreate seasonal-induced switching between states in bipolar disorder.
P2860
Q22252332-0ABC01FC-A04E-4AA8-8592-921E00BDC739Q28084519-1DC847CF-A3D2-433A-A963-F68A703245F7Q28085253-5F015BF8-15E0-4171-BAF6-CCA008E9DAC7Q30357298-4E131723-2F01-42FA-AB12-6B8A528AAF16Q30412810-A6A1B1DD-0078-4D69-8592-F42427185444Q30462823-F92771AD-33C9-4048-9222-4B7389E1C8B4Q30480638-D6D035B9-DBA9-4910-AFB1-D803FBFA0A72Q30489750-73952C60-8228-44FB-91E4-0854DDD755B4Q30497415-75B5D19F-AE23-46AF-A938-9A46A17C1F53Q33432811-0836AF24-3AA0-4797-9ADB-CEDDE6A227F3Q33590698-A285B79B-1F81-43DA-B8D8-47E334ED7EE9Q33886688-7B61C1D1-A82D-4171-865B-0273EA539CF4Q34499376-7151EFEF-DA2B-49C1-8290-2C351188BE9BQ35054681-AC88EE7A-3200-4225-99EB-3C6AA6C5E169Q35295664-05AF628E-3F8D-4419-9B6D-12895149EFD3Q35308508-EFD201FC-B909-46D1-B797-08AC8447683CQ35662070-62A4690B-0A18-4C88-B298-46A4814563B3Q36087706-BDAA1AEF-43A6-40B5-BC36-D6B3CA5ACDE6Q36510848-E2696CF2-7A38-409F-B9EB-D60165976A90Q36598826-55BF6301-6C2B-4BBB-AD2C-E86567AD83C6Q36992394-7A41CFA2-7783-4A1B-8500-72D72AAF1AC1Q37577518-0119DF61-BE56-4321-9850-4E96889F28AAQ37585078-2E3B8659-9F39-4711-9B20-D53856C8997CQ38434567-B4596A4F-333D-40DE-B2C3-5506A26E364FQ38979799-867E90DC-4D78-4045-AEC7-D92C7D238AE8Q39717392-4DCC66E4-8C8B-47C9-925D-29DDDEDA98EBQ42694237-A11402D5-AD85-4D8B-890F-1D57BDF0A4F4Q42702891-AEF4174B-20EF-432B-ADF9-2040E136688DQ46667741-171312ED-4190-41ED-BA33-6F22AE46436FQ50420266-FB5D5630-D6B5-489E-A3AF-C631624FF97E
P2860
A dopamine transporter mutation associated with bipolar affective disorder causes inhibition of transporter cell surface expression.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
A dopamine transporter mutatio ...... orter cell surface expression.
@en
A dopamine transporter mutatio ...... orter cell surface expression.
@nl
type
label
A dopamine transporter mutatio ...... orter cell surface expression.
@en
A dopamine transporter mutatio ...... orter cell surface expression.
@nl
prefLabel
A dopamine transporter mutatio ...... orter cell surface expression.
@en
A dopamine transporter mutatio ...... orter cell surface expression.
@nl
P2093
P2860
P356
P1433
P1476
A dopamine transporter mutatio ...... orter cell surface expression.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.MP.4001730
P407
P577
2005-12-01T00:00:00Z